Sigilon Therapeutics Inc Revenue per Employee (SGTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sigilon Therapeutics Inc   (NASDAQ: SGTX)
 

Sigilon Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 104.65% in the second quarter 2023, year on year to cumulative value of $18 million, Sigilon Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 802,455, this marks a new company high.
Within the Healthcare sector Employees of 116 other companies have achieved higher revenue per employee. While Sigilon Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1140. Sigilon Therapeutics Inc has 22 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SGTX Revenue per Employee (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Revenue Change 104.65 % 53.49 % 32.86 % 118.39 % 6.62 %
Sales per Employee (TTM) $ 802,455 665,318 588,364 558,636 453,864
SGTX's Total Ranking # 1140 # 0 # 0 # 0 # 0
Seq. Revenue Change 21.45 % 83.74 % -37.82 % 47.49 % -8.91 %

SGTX Company Profile >> Back to SGTX Efficiency Comparisons >> Compare SGTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 70
Healthcare Sector # 117
Overall Market # 1140

Revenue per Employee Statistics
High Average Low
$ 802,455 $ 510,642 $ 134,455
(Jun 30 2023)   (Mar 31 2021)



Financial Statements
Sigilon Therapeutics Inc 's Revenue MRQ $ 6 Millions Visit SGTX's Income Statement
Sigilon Therapeutics Inc 's Revenues TTM $ 18 Millions Visit SGTX's aggregate revenue growth
What are SGTX's Sales? Visit SGTX's Sales by Segment




Other Ratios
Sigilon Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SGTX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SGTX's Competitors
Revenue per Employee for SGTX's Suppliers
Revenue per Employee for SGTX's Customers

You may also want to know
SGTX's Sales Growth Rates SGTX's Pe Price to earnings ratio SGTX's Receivables Turnover Ratio SGTX's Stock Quote
SGTX's Net Income Growth Rates SGTX's Ps Price to Sales ratio SGTX's Sales per Employee SGTX's Asset Turnover Ratio
SGTX's Net Margin SGTX's Pb Price to Book ratio SGTX's Financial Strength Ratios SGTX's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:00+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2023Number of Employees Jun 30 2023
Keenova Therapeutics Plc  1,396,125.00 $ 2,233.800  Million 1,600 
Paragon 28 inc   1,392,770.83 $ 200.559  Million 144 
Nektar Therapeutics  1,392,714.29 $ 87.741  Million 63 
Bristol myers Squibb Company  1,390,369.23 $ 45,187.000  Million 32,500 
Voyager Therapeutics Inc   1,382,056.74 $ 194.870  Million 141 
Scilex Holding Company  1,366,470.59 $ 46.460  Million 34 
Vir Biotechnology Inc   1,337,114.44 $ 490.721  Million 367 
Biogen Inc   1,329,533.33 $ 9,971.500  Million 7,500 
Jazz Pharmaceuticals Plc  1,302,042.91 $ 3,762.904  Million 2,890 
Puma Biotechnology Inc   1,285,586.59 $ 230.120  Million 179 
Petros Pharmaceuticals inc   1,284,113.67 $ 3.852  Million 3 
Imagenebio Inc   1,277,933.33 $ 19.169  Million 15 
Collegium Pharmaceutical Inc   1,267,673.76 $ 536.226  Million 423 
Thorne Healthtech Inc   1,267,067.91 $ 255.948  Million 202 
Aurinia Pharmaceuticals Inc   1,250,914.06 $ 160.117  Million 128 
Maravai Lifesciences Holdings Inc   1,250,379.31 $ 543.915  Million 435 
Arbutus Biopharma Corp  1,238,684.21 $ 23.535  Million 19 
Coherus Oncology inc   1,237,605.44 $ 181.928  Million 147 
Incyte Corporation  1,235,332.63 $ 3,513.286  Million 2,844 
Cidara Therapeutics Inc   1,229,623.19 $ 84.844  Million 69 
Privia Health Group Inc   1,229,159.87 $ 1,506.950  Million 1,226 
Agenus Inc  1,226,604.94 $ 99.355  Million 81 
Sarepta Therapeutics Inc   1,201,717.37 $ 1,003.434  Million 835 
Emergent Biosolutions Inc   1,192,444.44 $ 1,073.200  Million 900 
Alpine Immune Sciences Inc   1,164,920.00 $ 29.123  Million 25 
Acorda Therapeutics Inc   1,146,215.69 $ 116.914  Million 102 
Palvella Therapeutics Inc   1,145,068.97 $ 33.207  Million 29 
Progyny Inc   1,117,671.73 $ 956.727  Million 856 
Cano Health Inc   1,103,281.85 $ 2,978.861  Million 2,700 
Xenetic Biosciences Inc   1,079,035.50 $ 2.158  Million 2 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.